首页>
外国专利>
POLYPEPTIDE HAVING AN INHIBITORY EFFECT ON VASOCONSTRICTION INDUCED BY PLASMINOGEN ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
POLYPEPTIDE HAVING AN INHIBITORY EFFECT ON VASOCONSTRICTION INDUCED BY PLASMINOGEN ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
展开▼
机译:多肽对溶酶原激活剂和包含相同成分的药物组合物引起的血管收缩具有抑制作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Compositions of the polypeptide EEIIMI, Ac-RMAPEEIMDRPFLYVVR-amide, anti-LRP antibodies, LRP antagonists, and/or one or more fibrinolytic agents are formulated for enhancing the fibrinolytic activity, reducing the side effects due to vasoactivity caused by the fibrinolytic agents, and/or prologing the half lives of the fibrinolytic agents. The invention further relates to combination compositions and/or therapy regimens, comprising the polypeptide EEIIMI and/or Ac-RMAPEEIIMDRPFLYVVR-amide and one or more currently used plasminogen activators.
展开▼